Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]
Doctors Link Shortage of Children’s Medications to Spike in Respiratory Infections
In the last few months, parents and caregivers of children have struggled to find over-the-counter and prescription medications used to treat common childhood illnesses like influenza, ear infections and sore throats for their sick children.1 2 The four medications reportedly in short supply are Amoxicillin (an antibiotic), Tamiflu (an antiviral), Albuterol (a bronchodilator) and children’s Tylenol […]
Pfizer’s New RSV Vaccine for Pregnant Women on Fast Track
Amongst frantic media coverage of increases in cases of (RSV) among children, Pfizer has announced the development of an experimental bivalent RSV vaccine for pregnant mothers in an attempt to protect newborns from being infected with the virus. The pharmaceutical giant plans to submit the results of their RSV vaccine clinical trials to the U.S. […]
Is a Bill Requiring Your Children to Get Every CDC Recommended Vaccination Coming to Your State?
As vaccine-related bills are being introduced into state legislatures this month, a bill (HB1090) has been proposed in the Virginia legislature to require school children to receive every dose of all current and future vaccines added to the recommended childhood vaccine schedule by the Advisory Committee on Immunization Practices (ACIP) appointed by the U.S. Centers […]